InMode vs TransMedics
INMD and TMDX side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How INMD and TMDX compare
TransMedics grew revenue faster over the last twelve months (28.5% versus −6.2% for InMode).
TransMedics scores higher on the StockData Score (15 against 6 for InMode), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | INMD | TMDX |
|---|---|---|
| Size and price | ||
| Market cap | – | $3.2B |
| Share price | $13.27 | $91.38 |
| Change, 1 year | −9.2% | −23.3% |
| Change, 5 years | −85.0% | 301% |
| Beta (5Y) | 1.43 | 1.34 |
| Employees | 660 | 898 |
| StockData Score | ||
| Total score | 6 | 15 (better) |
| Valuation score | 0 | 5 (better) |
| Growth score | 0 | 2 (better) |
| Performance score | 1 | 4 (better) |
| Health score | 5 (better) | 4 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 25.0× |
| P/S | – | 4.4× |
| P/B | – | 5.8× |
| EV/EBITDA | – | 21.5× |
| P/FCF | – | 70.9× |
| FCF yield | – | 1.4% |
| Fair value | – | $129.52 |
| Margin of safety | – | 29.4% |
| Growth | ||
| Revenue growth (TTM) | −6.2% | 28.5% (better) |
| Revenue growth, 5Y average | 12.4% | 88.2% (better) |
| Net income growth (TTM) | – | 57.4% |
| EPS growth (TTM) | −36.4% | 47.8% (better) |
| EPS growth, 5Y average | 9.9% | – |
| Profitability | ||
| Gross margin | 78.5% (better) | 58.6% |
| Operating margin | 23.0% (better) | 11.9% |
| Net margin | – | 19.9% |
| FCF margin | 22.7% (better) | 6.1% |
| Return on equity | – | 31.9% |
| Return on invested capital | 25.1% | 2622% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.10 (better) |
| Net debt / EBITDA | – | −3.45 |
| Interest coverage | – | 3.5× |
| Current ratio | 9.88 (better) | 4.53 |
| Altman Z-score | – | 2.84 |
| Piotroski F-score | – | 6 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.00% |
| Years of dividend growth | – | 0 |
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 49.5% | 100% |
| Held by insiders | 12.0% | 3.9% |
| Insider net buying, 12 months | – | −$4.2M |
| Short interest, % of float | 4.1% | 26.6% |
Go deeper
- INMD stock overview
- INMD income statement
- INMD valuation and score
- TMDX stock overview
- TMDX income statement
- TMDX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.